Skip to main content
Download PDF

Volume 2 Supplement 1

2nd Scientific Meeting of the Head and Neck Optical Diagnostics Society

Photochemical internalization

Head & Neck Oncology volume 2, Article number: O44 (2010) Cite this article

Introduction/aims

Photochemical internalization (PCI) is a novel technology facilitates the delivery of macromolecules into cytoplasm. The initial mechanism and practical application was described by Berg et al. in 1999.

This, first in human trial, is an open, phase I dose escalating study to evaluate the safety and tolerance of the photosensitizer (amphinex) that is used to initiate the photochemical internalization process with bleomycin as the chemotherapeutic agent. We present our preliminary report following the management of 11 patients with head and neck tumours.

Material/methods

Patients monitoring and follow-up start from Day -14 and continue to Day 28. The drug safety and tolerance are assessed by measuring the concentration (PK) of amphinex in plasma and urine after centrifugation and samples freezing under -20°C. Assessment of amphinex accumulation in skin is performed by fluorescence spectroscopy. Skin sensitivity testing is conducted using white light.

Results

The 11 patients in this trial received 0.25-1.0mg/kg amphinex (Day 0) approximately 93hrs prior to a slow bleomycin infusion (15000u/m2) and subsequent illumination (Day 4) with 652nm diode laser with 60J/cm2to initiate PCI. No immediate clinical symptoms were reported prior to amphinex administration and no immediate drug adverse events were identified.

Conclusions

The most striking finding is the dramatic tumour responses. Complete tumour response of the target lesions of 10/11 patients was achieved. The starting dose of Amphinex for the study was set at a level not expected to trigger a PCI response, however there appeared to be a localized synergistic effect with photo-activation.

Author information

Affiliations

  1. UCL Department of Surgery, University College London Medical School, London, UK

    Waseem Jerjes, Charles Mosse, Zaid Hamdoon, Dawn Carnell, Kristian Berg, Anders Høgset & Colin Hopper

Authors
  1. Waseem Jerjes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles Mosse
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zaid Hamdoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dawn Carnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kristian Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anders Høgset
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Colin Hopper
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Waseem Jerjes.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Jerjes, W., Mosse, C., Hamdoon, Z. et al. Photochemical internalization. Head Neck Oncol 2, O44 (2010). https://doi.org/10.1186/1758-3284-2-S1-O44

Download citation

Keywords

  • Tumour Response
  • Bleomycin
  • Target Lesion
  • Drug Adverse Event
  • Complete Tumour

Head & Neck Oncology

ISSN: 1758-3284